肾癌手术后高血压与心血管疾病风险
本研究纳入898例cT1-2N0M0肾肿瘤且无心血管事件史患者,比较保留肾单位手术(NSS)与根治性肾切除术(RN)后两类心血管事件。RN与更高高血压风险独立相关(HR 2.89),但主要心血管事件风险与NSS相似(HR 0.85)。RN后高血压多在术后早期发生,而其他心血管事件长期逐渐出现。
要点
- 与RN相比,NSS对术后高血压有独立保护作用(HR 2.89,p=0.006)。
- NSS与RN的主要心血管事件风险无显著差异(HR 0.85,p=0.6)。
- RN后高血压事件38%发生在术后即刻,NSS后仅10%在6个月内发生。
核心结论
- 与根治性肾切除术相比,保留肾单位手术对术后高血压有独立保护作用,但对主要心血管事件无显著保护作用。
研究设计与样本
- 回顾性队列研究,纳入898例cT1-2N0M0肾肿瘤且无心血管事件史的患者,比较NSS与RN。
主要发现
- RN组38%的高血压事件发生在术后即刻,而NSS组仅10%发生在术后6个月内。
- 主要心血管事件在两组均呈长期时间依赖性增加,但无统计学显著差异。
- 多因素分析显示RN与更高高血压风险相关(HR 2.89;p=0.006),主要心血管事件风险与NSS相似(HR 0.85;p=0.6)。
临床怎么用
- 对于无心血管病史的肾肿瘤患者,选择保留肾单位手术可能降低术后高血压风险。
- RN术后应早期监测高血压,NSS术后长期监测其他心血管事件。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite better renal function following nephron-sparing surgery (NSS) relative to radical nephrectomy (RN), there is no consensus with respect to the long-term sequelae associated with surgery. OBJECTIVE: To investigate the effect of surgery and the temporal pattern of two different cardiovascular event (CVe) categories after NSS versus RN. DESIGN, SETTING, AND PARTICIPANTS: We collected data of 898 patients with cT1-2 N0 M0 renal mass and no history of CVe treated with NSS versus RN. CVe categories were dichotomised in (1) de novo hypertension (HT) and (2) other major cardiovascular events (MCEs). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Multivariable competing regression analyses (MVAs) tested the adjusted effect of surgery type on each CVe category. RESULTS AND LIMITATIONS: Among patients treated with RN, 38% of HT events occurred immediately after surgery. Conversely, in NSS counterparts, the onset of HT was diluted over the years after surgery (10% of HT events in the first 6 mo). When an MCE was considered, an increasing long-term time-dependent prevalence of the outcome was observed in both groups, with no statistically significantly difference between NSS and RN. At MVA, RN was associated with a higher HT risk (hazard ratio [HR] 2.89; p=0.006) than but a similar MCE risk (HR 0.85; p=0.6) to NSS. CONCLUSIONS: Relative to RN, NSS showed an independent protective effect on HT but not on MCEs. In patients with no history of preoperative HT or MCEs, the onset of HT after RN is a very early event, due probably to the acute loss of renal parenchyma. This is not the case for the other cardiovascular morbidity, which develops in the long-term period, regardless of the type of surgery performed. PATIENT SUMMARY: In renal cancer patients without a medical history of cardiopathy, preserving healthy kidney tissue at surgery is associated with a decreased risk of developing postoperative hypertension.
引用
- Capitanio U, Larcher A, Cianflone F, et al. Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer. Eur Urol Oncol. 2019. PMID: 31411993. doi:10.1016/j.euo.2019.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。